EVEREST MED-B: Notification Letter with Request Form to Non-registered Holders
Apr 24 22:01
EVEREST MED-B: Notification Letter with Change Request Form to Registered Shareholders
Apr 24 21:59
EVEREST MED-B: 2023 Environmental, Social and Governance Report
Apr 24 21:55
EVEREST MED-B: 2023 Annual Report
Apr 24 21:51
EVEREST MED-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
Apr 8 16:30
EVEREST MED-B: (1) GRANT OF OPTIONS (2) GRANT OF AWARDS (3) NON-EXEMPTED CONNECTED TRANSACTIONS - PROPOSED AWARD GRANTS TO CONNECTED PERSONS
Apr 5 22:29
EVEREST MED-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Mar 28 06:45
EVEREST MED-B: VOLUNTARY ANNOUNCEMENT VOLUNTARY LOCK-UP UNDERTAKING BY CONTROLLING SHAREHOLDER AND CERTAIN SENIOR MANAGEMENT
Mar 18 06:55
EVEREST MED-B: DATE OF BOARD MEETING
Mar 6 07:03
EVEREST MED-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
Mar 5 19:54
EVEREST MED-B: UPDATE IN RELATION TO DISCLOSEABLE TRANSACTION - (1) COLLABORATION AND LICENSE AGREEMENT; AND (2) SHARE ISSUANCE AGREEMENT IN RESPECT OF THE MANUFACTURE, DEVELOPMENT AND COMMERCIALIZATION OF COVID-19 VACCINES AND CERTAIN LICENSED PRODUCTS
Feb 19 07:50
EVEREST MED-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Feb 9 15:49
EVEREST MED-B: CHANGE OF NON-EXECUTIVE DIRECTOR
Feb 9 15:48
EVEREST MED-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
Feb 6 18:22
EVEREST MED-B: VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE
Jan 22 06:56
EVEREST MED-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Jan 12 17:05
EVEREST MED-B: CHANGE OF NON-EXECUTIVE DIRECTOR
Jan 12 17:02
EVEREST MED-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
Jan 5 17:46
EVEREST MED-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
Dec 6, 2023 18:52
EVEREST MED-B: VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE ON THE APPROVAL OF NEW DRUG APPLICATION IN CHINA FOR NEFECON FOR THE TREATMENT OF PRIMARY IMMUNOGLOBULIN A NEPHROPATHY IN ADULTS AT RISK OF DISEASE PROGRESSION
Nov 24, 2023 12:00
No Data
No Data